Skip to content
10-Q

Quarterly Report

Histogen Inc.

0000950170-23-021301

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 11, 2023 4.27M sh
Shares Diluted Q1 2023 · Mar 31, 2023 4.27M sh
Shares Diluted Q1 2023 · Mar 31, 2022 2.5M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$2.55M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$345K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $9.66M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $12.11M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $17.85M
Stockholders Equity Q1 2023 · Mar 31, 2023 $11.35M
Stockholders Equity Q1 2023 · Dec 31, 2022 $14.41M
Current Liabilities Q1 2023 · Mar 31, 2023 $1.34M
Current Liabilities Q1 2023 · Dec 31, 2022 $1.23M
Total Liabilities Q1 2023 · Mar 31, 2023 $5.73M
Total Liabilities Q1 2023 · Dec 31, 2022 $5.7M
Current Assets Q1 2023 · Mar 31, 2023 $10.61M
Current Assets Q1 2023 · Dec 31, 2022 $13.46M
Total Assets Q1 2023 · Mar 31, 2023 $16.05M
Total Assets Q1 2023 · Dec 31, 2022 $19.07M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.81
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.27
Eps Basic Q1 2023 · Mar 31, 2023 −$0.81
Eps Basic Q1 2023 · Mar 31, 2022 −$0.27
Sga Expense Q1 2023 · Mar 31, 2023 $2.49M
Sga Expense Q1 2023 · Mar 31, 2022 $2.51M
Rd Expense Q1 2023 · Mar 31, 2023 $993K
Rd Expense Q1 2023 · Mar 31, 2022 $1.93M
Operating Income Q1 2023 · Mar 31, 2023 −$3.47M
Operating Income Q1 2023 · Mar 31, 2022 −$683K
Revenue Q1 2023 · Mar 31, 2023 $5K
Revenue Q1 2023 · Mar 31, 2022 $3.76M
Capex Q1 2023 · Mar 31, 2022 $15K